temozolomide

Poland

Drugs containing this active substance

  • TEMOZOLOMIDE FAIR-MED

    This is an anticancer medicine used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is administered first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in the case of tumor regrowth or disease progression (e.g., malignant glioma or anaplastic astrocytoma).

    Form: capsules, hard

    Active substance Dosage
    temozolomide 5 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Limited Fair-Med Healthcare GmbH

  • This is an anticancer medicine used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is administered first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in cases of tumor regrowth or disease progression (e.g., glioblastoma multiforme or anaplastic astrocytoma).

    Form: capsules, hard

    Active substance Dosage
    temozolomide 20 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Limited Fair-Med Healthcare GmbH

  • This is an anticancer medicine used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is used first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in cases of tumor regrowth or disease progression (e.g., glioblastoma multiforme or anaplastic astrocytoma).

    Form: capsules, hard

    Active substance Dosage
    temozolomide 100 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Limited

  • This medicine is used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is used first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in cases of tumor recurrence or disease progression (e.g., glioblastoma multiforme or anaplastic astrocytoma).

    Form: capsules, hard

    Active substance Dosage
    temozolomide 140 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Limited Fair-Med Healthcare GmbH

  • This is an anticancer medicine used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is administered first in combination with radiotherapy, and later as monotherapy. In children over 3 years of age and in adults, it is used in cases of tumor regrowth or disease progression (e.g., malignant glioma or anaplastic astrocytoma).

    Form: capsules, hard

    Active substance Dosage
    temozolomide 180 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Limited Fair-Med Healthcare GmbH

  • It is an anticancer medicine used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is used first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in the event of tumor regrowth or disease progression (e.g., glioblastoma multiforme or anaplastic astrocytoma).

    Form: capsules, hard

    Active substance Dosage
    temozolomide 250 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Limited Fair-Med Healthcare GmbH

  • This is an anticancer medicine used in the treatment of certain types of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is used first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in the case of tumor recurrence (e.g., glioblastoma multiforme or anaplastic astrocytoma) after standard treatment.

    Form: capsules, hard

    Active substance Dosage
    temozolomide 5 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Ltd., Glenmark Pharmaceuticals s.r.o.

  • This medicine is used to treat certain types of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is used first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in the event of tumor regrowth or disease progression (e.g., glioblastoma multiforme or anaplastic astrocytoma).

    Form: capsules, hard

    Active substance Dosage
    temozolomide 20 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Ltd., Glenmark Pharmaceuticals s.r.o.

  • This is an anticancer medicine used in the treatment of certain types of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is used first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in cases of tumor recurrence or disease progression (e.g., malignant glioma or anaplastic astrocytoma).

    Form: capsules, hard

    Active substance Dosage
    temozolomide 100 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Ltd., Glenmark Pharmaceuticals s.r.o.

  • This is an anticancer medicine used to treat certain types of brain tumors: in adults with newly diagnosed glioblastoma multiforme and in children (from 3 years of age) and adults with malignant glioma (e.g., anaplastic astrocytoma), if the tumor has recurred.

    Form: capsules, hard

    Active substance Dosage
    temozolomide 140 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Ltd., Glenmark Pharmaceuticals s.r.o.

  • The medicinal product is used to treat certain types of brain tumors: in adults with newly diagnosed glioblastoma multiforme (first with radiotherapy, then alone) and in children over 3 years of age and adults with malignant glioma (e.g., anaplastic astrocytoma), if the tumor has recurred or the disease has progressed.

    Form: capsules, hard

    Active substance Dosage
    temozolomide 180 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Ltd., Glenmark Pharmaceuticals s.r.o.

  • It is an anticancer medicine used to treat certain types of brain tumors: in adults with newly diagnosed glioblastoma multiforme, and in children (from 3 years of age) and adults with malignant glioma (e.g., anaplastic astrocytoma), if the tumor has recurred or the disease has progressed.

    Form: capsules, hard

    Active substance Dosage
    temozolomide 250 mg

    ATC: L01AX03

    Manufacturer: EirGen Pharma Ltd., Glenmark Pharmaceuticals s.r.o.